mRNA-1273

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instanceOf vaccine
gptkbp:administeredBy intramuscular injection
gptkbp:age 6 months and older
gptkbp:alsoKnownAs gptkb:Moderna_COVID-19_Vaccine
gptkb:Spikevax
gptkbp:approvedBy gptkb:WHO
gptkb:FDA
gptkb:EMA
gptkbp:boosterDoseInterval at least 5 months after second dose
gptkbp:boosters yes
gptkbp:CDCRecommended yes
gptkbp:clinicalTrialPhase July 2020
gptkbp:contains mRNA encoding SARS-CoV-2 spike protein
gptkbp:containsAdjuvant no
gptkbp:containsEggProducts no
gptkbp:containsLatex no
gptkbp:containsMeat no
gptkbp:containsPreservatives no
gptkbp:countryOfOrigin gptkb:United_States
gptkbp:developedBy gptkb:Moderna
gptkbp:distribution global
gptkbp:efficacyAgainstOriginalStrain ~94%
gptkbp:EMARecommended yes
gptkbp:emergencyServices December 2020
gptkbp:emergencyUseCountries gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:Japan
gptkb:United_Kingdom
gptkb:United_States
gptkbp:form 2 doses
gptkbp:fullApprovalDate January 2022
https://www.w3.org/2000/01/rdf-schema#label mRNA-1273
gptkbp:includedInCOVAX yes
gptkbp:manufacturer gptkb:Moderna,_Inc.
gptkbp:patent gptkb:Moderna,_Inc.
gptkbp:pregnancyCategory consult healthcare provider
gptkbp:primarySeriesInterval 28 days between doses
gptkbp:sideEffect fever
fatigue
headache
muscle pain
chills
injection site pain
gptkbp:storage -20°C
gptkbp:target gptkb:COVID-19
gptkbp:technology vaccine
gptkbp:variantBoosterAvailable yes
gptkbp:variantBoosterType bivalent (Omicron-containing)
gptkbp:WHOEmergencyUseListing April 2021
gptkbp:bfsParent gptkb:Moderna
gptkbp:bfsLayer 4